Literature DB >> 16890648

Second primary malignancies associated with renal cell carcinoma histological subtypes.

R Houston Thompson1, Bradley C Leibovich, John C Cheville, W Scott Webster, Christine M Lohse, Eugene D Kwon, Horst Zincke, Michael L Blute.   

Abstract

PURPOSE: Renal cell carcinoma has been linked to numerous secondary malignancies. We evaluated the risk of secondary malignancies by renal cell carcinoma histological subtype in patients with clear cell, papillary and chromophobe renal cell carcinoma.
MATERIALS AND METHODS: We studied 2,722 patients who underwent nephrectomy for sporadic renal cell carcinoma at our institution between 1970 and 2000. All specimens were reviewed by a single urological pathologist for histological subtype. Associations of second primary malignancies by histological subtype were evaluated using the chi-square and Fisher exact tests.
RESULTS: Of the patients studied 2,188 (80.4%) had clear cell, 378 (13.9%) had papillary and 128 (4.7%) had chromophobe renal cell carcinoma. Patients with papillary renal cell carcinoma were significantly more likely to have colon cancer (p = 0.041), prostate cancer (p = 0.003), any second malignancy (p <0.001) and multiple malignancies (p <0.001) compared with patients with clear cell renal cell carcinoma. In addition, patients with chromophobe renal cell carcinoma were significantly more likely to have colon cancer than patients with clear cell renal cell carcinoma (p = 0.020). Although patients with papillary renal cell carcinoma were more likely to have bladder cancer, the incidence did not differ significantly compared with that in patients harboring clear cell and chromophobe renal cell carcinoma (p = 0.193). We did not find a significant difference in the incidence of breast cancer, lung cancer, rectal cancer or lymphoma among histological subtypes.
CONCLUSIONS: Our data indicate that patients with papillary renal cell carcinoma are more likely to harbor secondary malignancies, including colon and prostate cancer, than patients with clear cell renal cell carcinoma. These results may have important implications for patient education and followup evaluation, and they should prompt mechanistic investigations.

Entities:  

Mesh:

Year:  2006        PMID: 16890648     DOI: 10.1016/j.juro.2006.04.080

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Incidence and prognostic significance of second primary cancers in renal cell carcinoma.

Authors:  Subhankar Chakraborty; Stefano R Tarantolo; Surinder K Batra; Ralph J Hauke
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

2.  Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.

Authors:  Katie S Murray; Emily C Zabor; Massimiliano Spaliviero; Paul Russo; Wassim M Bazzi; John E Musser; A Ari Hakimi; Melanie L Bernstein; Guido Dalbagni; Jonathan A Coleman; Helena Furberg
Journal:  World J Urol       Date:  2016-04-22       Impact factor: 4.226

3.  Multiple primary malignancies: analysis of 23 patients with at least three tumors.

Authors:  Ahmed Salem; Ramiz Abu-Hijlih; Fadwa Abdelrahman; Rim Turfa; Rula Amarin; Naim Farah; Maher Sughayer; Abdelatief Almousa; Jamal Khader
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  [Atypical metastasis of renal cell carcinoma. Contribution of comparative genomic hybridisation to diagnosis].

Authors:  B Kazarians; I Kausch; F Noack; K Junker; D Jocham; C Doehn
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

5.  Contemporary epidemiology of renal cell cancer.

Authors:  Wong-Ho Chow; Susan S Devesa
Journal:  Cancer J       Date:  2008 Sep-Oct       Impact factor: 3.360

6.  Double primary tumors-renal cell carcinoma and duodenal mucinous adenocarcinoma.

Authors:  Nada Vuckovic; Bojana Andrejic; Matilda Djolai; Srdjan Zivojinov; Katarina Sarcev; Dejan Vuckovic
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

7.  Radiation induced esophageal adenocarcinoma in a woman previously treated for breast cancer and renal cell carcinoma.

Authors:  Soundouss Raissouni; Ferdaous Raissouni; Ghizlane Rais; Meryem Aitelhaj; Siham Lkhoyaali; Rachida Latib; Amina Mohtaram; Fadoua Rais; Hind Mrabti; Nawal Kabbaj; Naima Amrani; Hassan Errihani
Journal:  BMC Res Notes       Date:  2012-08-09

8.  Synchronous Renal Cell Carcinoma and Gastrointestinal Malignancies.

Authors:  Tamer J Dafashy; Cameron K Ghaffary; Kyle T Keyes; Joseph Sonstein
Journal:  Case Rep Urol       Date:  2016-01-19

9.  Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study.

Authors:  Jae Young Joung; Whi-An Kwon; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  Cancer Res Treat       Date:  2017-04-19       Impact factor: 4.679

10.  [Colon adenocarcinoma and synchronous type 1 papillary renal cell carcinoma: a unique association].

Authors:  Asma Sassi; Dhouha Bacha; Ghofrane Talbi; Sana Ben Slama; Rahma Boughriba; Zeineb Mzoughi; Saadia Bouraoui; Ahlem Lahmar
Journal:  Pan Afr Med J       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.